Through the budget rectification, CNAS has obtained a significant increase in funds for cost-volume contracts, from 6.2 billion lei to 8.5 billion lei. This amount will allow the continuation of treatments for patients benefiting from innovative therapies and will facilitate access for other patients to essential medications. The president of CNAS, Horațiu-Remus Moldovan, emphasized the importance of this decision for public health and invited pharmaceutical manufacturers to participate in negotiations for new contracts.
Sources
Cum arată rectificarea bugetară pentru Sănătate. Cât primește CNAS de la Guvern pentru medicamente și terapii inovatoare
CNAS a obţinut creşterea plafonului de negociere pentru contractele cost-volum la 8,5 miliarde lei, faţă de 6,2 miliarde lei la începutul anului / Asigură continuitatea tratamentelor pentru peste 450.000 de pacienţi care beneficiază de terapii moderne
Latest News
10:27
The European Union will cap imports of hybrid vehicles in an agreement with Beijing aimed at avoiding a trade escalation
10:15
Ukraine’s attacks on Russian data centers have silenced the pro-Trump and pro-AfD bots on social media
10:05
Apa Nova is temporarily suspending water supply in several areas of Bucharest
09:57
Panama recorded more than 200 aftershocks following the 7.7-magnitude earthquake, which damaged hundreds of homes and infrastructure in the country's central provinces
09:53
Three people died and two others were seriously injured in an accident on DN 67 in Vâlcea County
See more news